Jerry Ware
Concepts (430)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Platelets | 52 | 2022 | 306 | 7.640 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 37 | 2022 | 56 | 5.210 |
Why?
| Thrombosis | 16 | 2022 | 263 | 3.020 |
Why?
| Hemostasis | 14 | 2020 | 66 | 2.960 |
Why?
| von Willebrand Factor | 15 | 2022 | 55 | 2.420 |
Why?
| Platelet Membrane Glycoproteins | 14 | 2018 | 35 | 2.090 |
Why?
| Cell-Derived Microparticles | 6 | 2018 | 23 | 1.910 |
Why?
| Bernard-Soulier Syndrome | 7 | 2022 | 7 | 1.850 |
Why?
| Platelet Activation | 14 | 2020 | 67 | 1.850 |
Why?
| Sepsis | 4 | 2018 | 239 | 1.550 |
Why?
| von Willebrand Diseases | 5 | 2016 | 20 | 1.360 |
Why?
| Animals | 70 | 2022 | 14801 | 1.190 |
Why?
| Thrombocytopenia | 9 | 2019 | 94 | 1.170 |
Why?
| Neoplasms | 4 | 2019 | 1258 | 1.070 |
Why?
| Thrombin | 7 | 2016 | 55 | 1.060 |
Why?
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2013 | 43 | 1.040 |
Why?
| Mice | 48 | 2022 | 6389 | 1.040 |
Why?
| Cell Cycle Proteins | 6 | 2006 | 194 | 1.030 |
Why?
| Inflammation | 6 | 2022 | 671 | 1.020 |
Why?
| Hemorrhage | 7 | 2018 | 197 | 0.960 |
Why?
| Platelet Aggregation | 13 | 2019 | 93 | 0.930 |
Why?
| Mice, Knockout | 24 | 2020 | 1001 | 0.910 |
Why?
| Carcinoma, Lewis Lung | 2 | 2012 | 10 | 0.850 |
Why?
| Melanoma, Experimental | 2 | 2012 | 50 | 0.810 |
Why?
| Mice, Transgenic | 23 | 2019 | 725 | 0.730 |
Why?
| Mice, Inbred C57BL | 24 | 2021 | 2060 | 0.730 |
Why?
| Klebsiella Infections | 2 | 2018 | 12 | 0.720 |
Why?
| Klebsiella pneumoniae | 2 | 2018 | 21 | 0.710 |
Why?
| Pneumonia, Bacterial | 2 | 2018 | 27 | 0.710 |
Why?
| Phosphatidylserines | 1 | 2018 | 5 | 0.710 |
Why?
| Haplotypes | 1 | 2018 | 110 | 0.700 |
Why?
| Disease Models, Animal | 17 | 2022 | 1693 | 0.690 |
Why?
| Signal Transduction | 12 | 2018 | 1846 | 0.680 |
Why?
| Receptors, Proteinase-Activated | 3 | 2016 | 5 | 0.650 |
Why?
| Phenotype | 10 | 2018 | 840 | 0.640 |
Why?
| Megakaryocytes | 6 | 2017 | 26 | 0.640 |
Why?
| Cytoskeletal Proteins | 5 | 2006 | 62 | 0.630 |
Why?
| Hemorrhagic Disorders | 2 | 2013 | 6 | 0.610 |
Why?
| GTP Phosphohydrolases | 4 | 2004 | 34 | 0.600 |
Why?
| Blood Platelet Disorders | 3 | 2016 | 7 | 0.590 |
Why?
| Humans | 58 | 2022 | 52865 | 0.570 |
Why?
| GTP-Binding Proteins | 3 | 2006 | 95 | 0.570 |
Why?
| Point Mutation | 2 | 2013 | 80 | 0.570 |
Why?
| von Willebrand Disease, Type 2 | 1 | 2013 | 2 | 0.510 |
Why?
| Amino Acid Substitution | 1 | 2013 | 110 | 0.500 |
Why?
| RNA Splicing | 1 | 2013 | 34 | 0.480 |
Why?
| Platelet Transfusion | 6 | 2020 | 34 | 0.480 |
Why?
| Mutation, Missense | 1 | 2013 | 116 | 0.480 |
Why?
| Cell Lineage | 1 | 2013 | 100 | 0.480 |
Why?
| Communicable Diseases | 1 | 2013 | 48 | 0.480 |
Why?
| Blood Preservation | 3 | 2020 | 31 | 0.470 |
Why?
| Lung Neoplasms | 2 | 2009 | 598 | 0.460 |
Why?
| Single-Chain Antibodies | 1 | 2012 | 28 | 0.460 |
Why?
| Protein Binding | 12 | 2021 | 784 | 0.450 |
Why?
| Endothelium, Vascular | 3 | 2013 | 298 | 0.450 |
Why?
| Tumor Microenvironment | 1 | 2012 | 149 | 0.430 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 230 | 0.400 |
Why?
| Platelet Adhesiveness | 5 | 2013 | 21 | 0.400 |
Why?
| Blood Coagulation | 5 | 2018 | 79 | 0.400 |
Why?
| Neutrophils | 4 | 2018 | 162 | 0.390 |
Why?
| Collagen | 7 | 2016 | 234 | 0.380 |
Why?
| Neoplastic Cells, Circulating | 1 | 2010 | 92 | 0.380 |
Why?
| Cold Temperature | 2 | 2020 | 54 | 0.370 |
Why?
| Gene Deletion | 3 | 2007 | 292 | 0.360 |
Why?
| Septins | 7 | 2006 | 19 | 0.360 |
Why?
| Venous Thrombosis | 3 | 2018 | 111 | 0.350 |
Why?
| Renal Insufficiency, Chronic | 2 | 2022 | 154 | 0.350 |
Why?
| Mutation | 4 | 2016 | 1428 | 0.340 |
Why?
| Membrane Glycoproteins | 4 | 2013 | 295 | 0.330 |
Why?
| Recombinant Fusion Proteins | 3 | 2013 | 235 | 0.310 |
Why?
| Blood Vessels | 2 | 2020 | 84 | 0.310 |
Why?
| Bleeding Time | 5 | 2014 | 11 | 0.300 |
Why?
| Tubulin | 1 | 2006 | 22 | 0.300 |
Why?
| Microtubules | 1 | 2006 | 52 | 0.300 |
Why?
| Membrane Proteins | 3 | 2004 | 395 | 0.280 |
Why?
| Vena Cava, Inferior | 2 | 2018 | 80 | 0.270 |
Why?
| Immunoglobulins, Intravenous | 2 | 2017 | 58 | 0.270 |
Why?
| Monocytes | 3 | 2018 | 158 | 0.270 |
Why?
| Blood Proteins | 2 | 2018 | 104 | 0.270 |
Why?
| Ligands | 4 | 2014 | 254 | 0.250 |
Why?
| Bone and Bones | 1 | 2008 | 518 | 0.250 |
Why?
| Tumor Escape | 2 | 2015 | 23 | 0.240 |
Why?
| Nerve Tissue Proteins | 2 | 2002 | 217 | 0.240 |
Why?
| Flow Cytometry | 5 | 2013 | 582 | 0.240 |
Why?
| Neovascularization, Pathologic | 3 | 2015 | 175 | 0.240 |
Why?
| Receptors, Interleukin-4 | 1 | 2002 | 4 | 0.240 |
Why?
| Male | 17 | 2020 | 28240 | 0.230 |
Why?
| Cell Communication | 2 | 2014 | 73 | 0.230 |
Why?
| Integrins | 2 | 2020 | 39 | 0.230 |
Why?
| Neoplasm Invasiveness | 2 | 2015 | 303 | 0.220 |
Why?
| Thrombopoiesis | 3 | 2011 | 8 | 0.220 |
Why?
| Female | 15 | 2020 | 28888 | 0.220 |
Why?
| Homeostasis | 2 | 2020 | 237 | 0.220 |
Why?
| Antibodies, Monoclonal | 5 | 2017 | 562 | 0.220 |
Why?
| Radiation Protection | 1 | 2021 | 55 | 0.210 |
Why?
| Egtazic Acid | 1 | 2020 | 20 | 0.210 |
Why?
| Time Factors | 7 | 2020 | 3434 | 0.210 |
Why?
| Calcium | 3 | 2020 | 470 | 0.210 |
Why?
| Platelet Aggregation Inhibitors | 4 | 2022 | 209 | 0.200 |
Why?
| Tail | 3 | 2014 | 11 | 0.200 |
Why?
| Arthritis, Experimental | 2 | 2017 | 11 | 0.190 |
Why?
| Synovial Membrane | 2 | 2017 | 18 | 0.190 |
Why?
| Sertraline | 1 | 2019 | 47 | 0.190 |
Why?
| Melioidosis | 1 | 2019 | 5 | 0.180 |
Why?
| Burkholderia pseudomallei | 1 | 2019 | 9 | 0.180 |
Why?
| Protein Structure, Tertiary | 5 | 2013 | 299 | 0.180 |
Why?
| Severity of Illness Index | 2 | 2018 | 1113 | 0.180 |
Why?
| Proto-Oncogene Proteins c-kit | 2 | 2017 | 37 | 0.180 |
Why?
| Gray Platelet Syndrome | 1 | 2018 | 1 | 0.180 |
Why?
| Age of Onset | 1 | 2018 | 121 | 0.180 |
Why?
| Serotonin Uptake Inhibitors | 1 | 2019 | 121 | 0.180 |
Why?
| Thrombopoietin | 1 | 2018 | 10 | 0.170 |
Why?
| Cell Proliferation | 2 | 2015 | 1124 | 0.170 |
Why?
| Multiple Organ Failure | 1 | 2018 | 56 | 0.170 |
Why?
| Refrigeration | 1 | 2017 | 4 | 0.170 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2017 | 12 | 0.170 |
Why?
| src-Family Kinases | 2 | 2009 | 60 | 0.170 |
Why?
| Platelet Count | 4 | 2019 | 66 | 0.170 |
Why?
| Genetic Predisposition to Disease | 2 | 2018 | 582 | 0.170 |
Why?
| Genetic Association Studies | 1 | 2018 | 147 | 0.170 |
Why?
| Depressive Disorder, Major | 1 | 2019 | 155 | 0.170 |
Why?
| rhoA GTP-Binding Protein | 1 | 2017 | 7 | 0.160 |
Why?
| Mechanotransduction, Cellular | 1 | 2017 | 30 | 0.160 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 26 | 0.160 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2017 | 12 | 0.160 |
Why?
| Cell Differentiation | 3 | 2011 | 757 | 0.160 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2022 | 445 | 0.160 |
Why?
| Cell Line, Tumor | 3 | 2018 | 1503 | 0.160 |
Why?
| Cytokines | 3 | 2022 | 700 | 0.150 |
Why?
| Glycosphingolipids | 1 | 2016 | 3 | 0.150 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2016 | 25 | 0.150 |
Why?
| Membrane Microdomains | 1 | 2016 | 15 | 0.150 |
Why?
| Receptors, Purinergic P2 | 2 | 2009 | 40 | 0.150 |
Why?
| Microfilament Proteins | 2 | 2016 | 52 | 0.150 |
Why?
| Recombinant Proteins | 6 | 2018 | 594 | 0.150 |
Why?
| Plaque, Atherosclerotic | 1 | 2016 | 54 | 0.150 |
Why?
| Lentivirus | 2 | 2014 | 17 | 0.140 |
Why?
| Disease Progression | 1 | 2018 | 898 | 0.140 |
Why?
| Lectins, C-Type | 3 | 2020 | 34 | 0.140 |
Why?
| Anticarcinogenic Agents | 1 | 2015 | 47 | 0.140 |
Why?
| Liver Neoplasms | 1 | 2019 | 337 | 0.140 |
Why?
| Pancreatic Neoplasms | 1 | 2018 | 225 | 0.140 |
Why?
| Case-Control Studies | 1 | 2018 | 1262 | 0.140 |
Why?
| Carotid Artery Thrombosis | 1 | 2014 | 6 | 0.140 |
Why?
| Protein Subunits | 2 | 2007 | 87 | 0.140 |
Why?
| Amino Acid Sequence | 3 | 2013 | 813 | 0.130 |
Why?
| Liver | 2 | 2019 | 1266 | 0.130 |
Why?
| Phosphorylation | 4 | 2006 | 644 | 0.130 |
Why?
| Genetic Therapy | 2 | 2014 | 117 | 0.130 |
Why?
| Busulfan | 1 | 2014 | 18 | 0.130 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 263 | 0.130 |
Why?
| Molecular Sequence Data | 3 | 2013 | 1053 | 0.130 |
Why?
| Macrophage-1 Antigen | 1 | 2014 | 11 | 0.130 |
Why?
| Cell Death | 1 | 2015 | 238 | 0.130 |
Why?
| Neovascularization, Physiologic | 1 | 2014 | 79 | 0.130 |
Why?
| Neoplastic Stem Cells | 1 | 2015 | 103 | 0.130 |
Why?
| Collagen Type IV | 1 | 2013 | 13 | 0.130 |
Why?
| Mice, 129 Strain | 1 | 2014 | 52 | 0.130 |
Why?
| Ligation | 1 | 2014 | 67 | 0.130 |
Why?
| Interleukin-4 | 1 | 2014 | 51 | 0.130 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2013 | 9 | 0.130 |
Why?
| Transplantation Conditioning | 1 | 2014 | 86 | 0.130 |
Why?
| Aspirin | 1 | 2015 | 133 | 0.130 |
Why?
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2013 | 3 | 0.130 |
Why?
| Dermatitis, Contact | 1 | 2013 | 5 | 0.130 |
Why?
| Antibodies, Blocking | 1 | 2013 | 11 | 0.130 |
Why?
| Cecum | 1 | 2014 | 75 | 0.120 |
Why?
| Immune Complex Diseases | 1 | 2013 | 9 | 0.120 |
Why?
| Fibrinogen | 3 | 2009 | 47 | 0.120 |
Why?
| Endotoxemia | 1 | 2013 | 34 | 0.120 |
Why?
| Adenocarcinoma | 1 | 2018 | 435 | 0.120 |
Why?
| Platelet Membrane Glycoprotein IIb | 2 | 2009 | 5 | 0.120 |
Why?
| Atherosclerosis | 1 | 2016 | 273 | 0.120 |
Why?
| DNA-Binding Proteins | 1 | 2016 | 507 | 0.120 |
Why?
| Contractile Proteins | 1 | 2011 | 5 | 0.110 |
Why?
| Histocompatibility, Maternal-Fetal | 1 | 2011 | 1 | 0.110 |
Why?
| Cell Membrane | 4 | 2012 | 283 | 0.110 |
Why?
| Receptors, Fc | 1 | 2011 | 9 | 0.110 |
Why?
| Abortion, Spontaneous | 1 | 2011 | 20 | 0.110 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 58 | 0.110 |
Why?
| Cyclooxygenase 1 | 1 | 2011 | 7 | 0.110 |
Why?
| Epoprostenol | 1 | 2011 | 29 | 0.110 |
Why?
| Infant, Newborn | 1 | 2018 | 2767 | 0.110 |
Why?
| Synovitis | 1 | 2011 | 25 | 0.100 |
Why?
| Genetic Vectors | 1 | 2011 | 150 | 0.100 |
Why?
| Models, Biological | 1 | 2015 | 872 | 0.100 |
Why?
| Plateletpheresis | 1 | 2010 | 8 | 0.100 |
Why?
| Serotonin | 1 | 2012 | 160 | 0.100 |
Why?
| Peptides | 3 | 2018 | 283 | 0.100 |
Why?
| Genotype | 3 | 2017 | 636 | 0.100 |
Why?
| P-Selectin | 3 | 2019 | 43 | 0.100 |
Why?
| Bone Marrow Cells | 2 | 2009 | 245 | 0.100 |
Why?
| Tumor Burden | 1 | 2010 | 144 | 0.100 |
Why?
| Down-Regulation | 1 | 2012 | 402 | 0.100 |
Why?
| Synovial Fluid | 1 | 2010 | 19 | 0.100 |
Why?
| Killer Cells, Natural | 1 | 2010 | 109 | 0.100 |
Why?
| Anaphylaxis | 1 | 2010 | 71 | 0.100 |
Why?
| Infant | 1 | 2018 | 3694 | 0.100 |
Why?
| Adolescent | 2 | 2019 | 6866 | 0.100 |
Why?
| Carotid Artery Injuries | 1 | 2009 | 17 | 0.100 |
Why?
| Transplantation, Isogeneic | 1 | 2009 | 4 | 0.100 |
Why?
| Crosses, Genetic | 1 | 2009 | 35 | 0.090 |
Why?
| Child, Preschool | 1 | 2018 | 4140 | 0.090 |
Why?
| Immunoprecipitation | 2 | 2011 | 75 | 0.090 |
Why?
| Risk Factors | 1 | 2018 | 3984 | 0.090 |
Why?
| Haploidy | 1 | 2009 | 5 | 0.090 |
Why?
| Microscopy, Confocal | 1 | 2009 | 119 | 0.090 |
Why?
| Injections, Intravenous | 1 | 2009 | 161 | 0.090 |
Why?
| Arthritis, Rheumatoid | 1 | 2010 | 128 | 0.090 |
Why?
| Protein Transport | 2 | 2011 | 205 | 0.090 |
Why?
| Protein Conformation | 3 | 2017 | 234 | 0.090 |
Why?
| Embryonic Stem Cells | 1 | 2008 | 16 | 0.090 |
Why?
| Metalloproteases | 1 | 2008 | 10 | 0.090 |
Why?
| Receptors, Collagen | 2 | 2010 | 3 | 0.090 |
Why?
| Splenomegaly | 1 | 2008 | 15 | 0.080 |
Why?
| Cells, Cultured | 5 | 2018 | 1842 | 0.080 |
Why?
| Chromosomes | 1 | 2007 | 37 | 0.080 |
Why?
| Protein Structure, Secondary | 1 | 2008 | 104 | 0.080 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2013 | 168 | 0.080 |
Why?
| Hepatocytes | 2 | 2019 | 210 | 0.080 |
Why?
| Nocodazole | 1 | 2006 | 8 | 0.080 |
Why?
| Receptors, IgG | 2 | 2003 | 24 | 0.080 |
Why?
| Cell Adhesion Molecules | 1 | 2006 | 97 | 0.080 |
Why?
| Neoplasm Proteins | 1 | 2009 | 387 | 0.080 |
Why?
| Child | 1 | 2018 | 6934 | 0.070 |
Why?
| Tubulin Modulators | 1 | 2006 | 40 | 0.070 |
Why?
| Protein-Tyrosine Kinases | 1 | 2006 | 107 | 0.070 |
Why?
| Bone Marrow | 2 | 2011 | 413 | 0.070 |
Why?
| Apoptosis | 2 | 2020 | 1357 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 146 | 0.070 |
Why?
| Thromboplastin | 2 | 2018 | 11 | 0.070 |
Why?
| Collagen Type I | 1 | 2006 | 95 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2017 | 446 | 0.070 |
Why?
| Adenosine Triphosphate | 1 | 2006 | 235 | 0.070 |
Why?
| Consensus Sequence | 1 | 2004 | 29 | 0.070 |
Why?
| Ploidies | 1 | 2004 | 15 | 0.070 |
Why?
| 14-3-3 Proteins | 1 | 2004 | 21 | 0.070 |
Why?
| COS Cells | 1 | 2004 | 87 | 0.070 |
Why?
| Blood Cell Count | 1 | 2004 | 43 | 0.070 |
Why?
| CHO Cells | 3 | 2016 | 130 | 0.070 |
Why?
| Fluorescent Antibody Technique | 1 | 2004 | 144 | 0.070 |
Why?
| Osteoclasts | 1 | 2008 | 461 | 0.070 |
Why?
| Mice, Inbred BALB C | 2 | 2018 | 380 | 0.070 |
Why?
| Microscopy, Electron, Transmission | 1 | 2004 | 86 | 0.070 |
Why?
| Receptors, Thrombin | 2 | 2014 | 18 | 0.060 |
Why?
| Interleukin-1 | 2 | 2017 | 116 | 0.060 |
Why?
| Crotalid Venoms | 1 | 2003 | 10 | 0.060 |
Why?
| Receptors, Cell Surface | 1 | 2004 | 137 | 0.060 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 180 | 0.060 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 183 | 0.060 |
Why?
| Melanoma | 1 | 2007 | 318 | 0.060 |
Why?
| Cell Division | 1 | 2004 | 369 | 0.060 |
Why?
| Saccharomyces cerevisiae | 1 | 2004 | 208 | 0.060 |
Why?
| Mutagenesis | 1 | 2003 | 79 | 0.060 |
Why?
| Cell Size | 1 | 2002 | 47 | 0.060 |
Why?
| Albuminuria | 1 | 2022 | 45 | 0.060 |
Why?
| Terminology as Topic | 1 | 2002 | 72 | 0.060 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2002 | 52 | 0.060 |
Why?
| Hematopoiesis | 1 | 2002 | 85 | 0.060 |
Why?
| In Situ Hybridization | 1 | 2002 | 88 | 0.060 |
Why?
| Neurotransmitter Agents | 1 | 2002 | 35 | 0.060 |
Why?
| Sequence Homology, Amino Acid | 1 | 2002 | 195 | 0.050 |
Why?
| Fibroblasts | 2 | 2017 | 379 | 0.050 |
Why?
| Synapses | 1 | 2002 | 92 | 0.050 |
Why?
| Phospholipase C gamma | 1 | 2020 | 5 | 0.050 |
Why?
| Transgenes | 2 | 2014 | 63 | 0.050 |
Why?
| Meninges | 1 | 2020 | 13 | 0.050 |
Why?
| Integrin beta3 | 2 | 2011 | 11 | 0.050 |
Why?
| RNA, Messenger | 1 | 2004 | 1282 | 0.050 |
Why?
| E-Selectin | 1 | 2019 | 21 | 0.050 |
Why?
| Intention to Treat Analysis | 1 | 2019 | 30 | 0.050 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2013 | 48 | 0.050 |
Why?
| Arachidonic Acid | 1 | 2019 | 39 | 0.050 |
Why?
| Placebos | 1 | 2019 | 98 | 0.050 |
Why?
| Up-Regulation | 1 | 2002 | 536 | 0.050 |
Why?
| Kupffer Cells | 1 | 2019 | 18 | 0.050 |
Why?
| Glomerular Filtration Rate | 1 | 2019 | 143 | 0.050 |
Why?
| Asia, Southeastern | 1 | 2019 | 11 | 0.050 |
Why?
| Endothelium | 1 | 2019 | 45 | 0.050 |
Why?
| Cytoplasmic Granules | 1 | 2019 | 25 | 0.050 |
Why?
| Hyaluronic Acid | 1 | 2019 | 32 | 0.050 |
Why?
| Pancreatic Elastase | 1 | 2018 | 10 | 0.040 |
Why?
| Peroxidase | 1 | 2018 | 22 | 0.040 |
Why?
| N-Acetylneuraminic Acid | 1 | 2018 | 16 | 0.040 |
Why?
| Bacteriocins | 1 | 2018 | 1 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 2018 | 8 | 0.040 |
Why?
| Factor Xa | 1 | 2018 | 7 | 0.040 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2018 | 102 | 0.040 |
Why?
| Protein Unfolding | 1 | 2017 | 5 | 0.040 |
Why?
| Glycosylation | 1 | 2018 | 111 | 0.040 |
Why?
| Shear Strength | 1 | 2017 | 12 | 0.040 |
Why?
| Transfection | 3 | 2004 | 439 | 0.040 |
Why?
| Binding, Competitive | 1 | 2017 | 134 | 0.040 |
Why?
| Cell Polarity | 1 | 2017 | 18 | 0.040 |
Why?
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2017 | 4 | 0.040 |
Why?
| Double-Blind Method | 1 | 2019 | 756 | 0.040 |
Why?
| Skin | 1 | 2020 | 442 | 0.040 |
Why?
| Adenosine Diphosphate | 1 | 2016 | 28 | 0.040 |
Why?
| Blood Coagulation Tests | 1 | 2016 | 24 | 0.040 |
Why?
| Drug Design | 1 | 2018 | 148 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2018 | 134 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2018 | 185 | 0.040 |
Why?
| Cell Degranulation | 1 | 2016 | 4 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2018 | 153 | 0.040 |
Why?
| Mast Cells | 1 | 2017 | 71 | 0.040 |
Why?
| Survival Analysis | 1 | 2019 | 791 | 0.040 |
Why?
| Receptors, Purinergic P2Y12 | 2 | 2009 | 18 | 0.040 |
Why?
| Blood Component Removal | 1 | 2016 | 19 | 0.040 |
Why?
| Fibrinolytic Agents | 1 | 2018 | 149 | 0.040 |
Why?
| Body Weight | 1 | 2019 | 601 | 0.040 |
Why?
| Gryllidae | 2 | 1986 | 2 | 0.040 |
Why?
| Orthoptera | 2 | 1986 | 2 | 0.040 |
Why?
| Cricetulus | 1 | 2016 | 102 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 2016 | 61 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2017 | 229 | 0.040 |
Why?
| DNA, Ribosomal | 2 | 1986 | 27 | 0.040 |
Why?
| Mice, SCID | 1 | 2016 | 201 | 0.040 |
Why?
| Apolipoproteins E | 1 | 2016 | 63 | 0.040 |
Why?
| Protein Multimerization | 1 | 2016 | 55 | 0.040 |
Why?
| Middle Aged | 3 | 2019 | 13614 | 0.030 |
Why?
| Brain | 1 | 2004 | 1458 | 0.030 |
Why?
| Endothelial Cells | 1 | 2017 | 289 | 0.030 |
Why?
| Kinetics | 1 | 2016 | 740 | 0.030 |
Why?
| Gene Transfer Techniques | 1 | 2014 | 43 | 0.030 |
Why?
| Immune System | 1 | 2014 | 56 | 0.030 |
Why?
| Hydroxylation | 1 | 2013 | 61 | 0.030 |
Why?
| Tyrosine | 2 | 2006 | 150 | 0.030 |
Why?
| Base Sequence | 3 | 2003 | 773 | 0.030 |
Why?
| Chemotaxis, Leukocyte | 1 | 2013 | 21 | 0.030 |
Why?
| Cell Adhesion | 2 | 2006 | 186 | 0.030 |
Why?
| Cattle | 1 | 2013 | 225 | 0.030 |
Why?
| Proteolysis | 1 | 2013 | 103 | 0.030 |
Why?
| Adoptive Transfer | 1 | 2013 | 38 | 0.030 |
Why?
| Ferric Compounds | 1 | 2012 | 17 | 0.030 |
Why?
| Prospective Studies | 1 | 2019 | 2453 | 0.030 |
Why?
| Cricetinae | 2 | 2003 | 211 | 0.030 |
Why?
| Factor XII | 1 | 2012 | 2 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2013 | 219 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 2014 | 256 | 0.030 |
Why?
| rab4 GTP-Binding Proteins | 1 | 2012 | 8 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2013 | 324 | 0.030 |
Why?
| Transglutaminases | 1 | 2012 | 17 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 214 | 0.030 |
Why?
| Phosphoproteins | 1 | 2013 | 122 | 0.030 |
Why?
| Chlorides | 1 | 2012 | 58 | 0.030 |
Why?
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2011 | 1 | 0.030 |
Why?
| Binding Sites | 2 | 2003 | 471 | 0.030 |
Why?
| Blotting, Western | 1 | 2013 | 721 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 215 | 0.030 |
Why?
| Immunoblotting | 1 | 2011 | 138 | 0.030 |
Why?
| Histocompatibility Antigens Class I | 1 | 2011 | 47 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2011 | 164 | 0.030 |
Why?
| Antibodies | 1 | 2011 | 175 | 0.030 |
Why?
| Isotonic Solutions | 1 | 2010 | 22 | 0.030 |
Why?
| Aged, 80 and over | 1 | 2019 | 3624 | 0.020 |
Why?
| Sodium Chloride | 1 | 2010 | 68 | 0.020 |
Why?
| Proline | 1 | 2009 | 29 | 0.020 |
Why?
| Arthritis | 1 | 2010 | 51 | 0.020 |
Why?
| Hypersensitivity | 1 | 2010 | 74 | 0.020 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 533 | 0.020 |
Why?
| Hematopoietic Stem Cells | 1 | 2011 | 231 | 0.020 |
Why?
| Frameshift Mutation | 1 | 2009 | 17 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2010 | 122 | 0.020 |
Why?
| Blood Pressure | 1 | 2012 | 598 | 0.020 |
Why?
| Genes | 2 | 1986 | 40 | 0.020 |
Why?
| Young Adult | 1 | 2019 | 4295 | 0.020 |
Why?
| Dipeptides | 1 | 2008 | 20 | 0.020 |
Why?
| Family Health | 1 | 2009 | 84 | 0.020 |
Why?
| Gene Expression | 1 | 2011 | 721 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2009 | 197 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2008 | 65 | 0.020 |
Why?
| Genome | 1 | 2007 | 71 | 0.020 |
Why?
| Pseudopodia | 1 | 2006 | 4 | 0.020 |
Why?
| Interleukin-4 Receptor alpha Subunit | 1 | 2006 | 6 | 0.020 |
Why?
| Arteries | 1 | 2007 | 111 | 0.020 |
Why?
| Arterioles | 1 | 2006 | 35 | 0.020 |
Why?
| Models, Animal | 1 | 2007 | 267 | 0.020 |
Why?
| Adult | 2 | 2019 | 14316 | 0.020 |
Why?
| Laminin | 1 | 2006 | 34 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2006 | 162 | 0.020 |
Why?
| Drug Combinations | 1 | 2006 | 138 | 0.020 |
Why?
| Proteoglycans | 1 | 2006 | 97 | 0.020 |
Why?
| Fibroblast Growth Factors | 1 | 2006 | 60 | 0.020 |
Why?
| Cornea | 1 | 2006 | 64 | 0.020 |
Why?
| Hemoglobins | 1 | 2006 | 124 | 0.020 |
Why?
| Glycoproteins | 1 | 2006 | 139 | 0.020 |
Why?
| RNA, Ribosomal | 1 | 1985 | 19 | 0.020 |
Why?
| Pyrimidines | 1 | 2006 | 198 | 0.020 |
Why?
| Aged | 1 | 2019 | 10428 | 0.020 |
Why?
| Agglutination Tests | 1 | 2004 | 6 | 0.020 |
Why?
| Pregnancy | 1 | 2011 | 2432 | 0.020 |
Why?
| Models, Statistical | 1 | 2006 | 267 | 0.020 |
Why?
| Drosophila melanogaster | 1 | 2004 | 24 | 0.020 |
Why?
| Hydrogen Bonding | 1 | 2003 | 47 | 0.020 |
Why?
| Crystallization | 1 | 2003 | 44 | 0.020 |
Why?
| DNA, Complementary | 1 | 2003 | 158 | 0.020 |
Why?
| Alprostadil | 1 | 2003 | 11 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 318 | 0.010 |
Why?
| Crystallography, X-Ray | 1 | 2003 | 176 | 0.010 |
Why?
| Heterozygote | 1 | 2003 | 93 | 0.010 |
Why?
| Cyclic AMP | 1 | 2003 | 117 | 0.010 |
Why?
| DNA Primers | 1 | 2003 | 242 | 0.010 |
Why?
| Alternative Splicing | 1 | 2002 | 62 | 0.010 |
Why?
| Cell Fractionation | 1 | 2002 | 19 | 0.010 |
Why?
| Macromolecular Substances | 1 | 2002 | 49 | 0.010 |
Why?
| Zinc Fingers | 1 | 2002 | 26 | 0.010 |
Why?
| Dimerization | 1 | 2002 | 62 | 0.010 |
Why?
| Microscopy, Electron | 1 | 2002 | 98 | 0.010 |
Why?
| Excitatory Postsynaptic Potentials | 1 | 2002 | 40 | 0.010 |
Why?
| Electrophysiology | 1 | 2002 | 69 | 0.010 |
Why?
| Spectrometry, Fluorescence | 1 | 2002 | 57 | 0.010 |
Why?
| Brain Chemistry | 1 | 2002 | 84 | 0.010 |
Why?
| Models, Molecular | 1 | 2003 | 430 | 0.010 |
Why?
| Phylogeny | 1 | 2002 | 270 | 0.010 |
Why?
| Fungal Proteins | 1 | 2002 | 135 | 0.010 |
Why?
| Plasmids | 1 | 2002 | 186 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2002 | 114 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 970 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2002 | 204 | 0.010 |
Why?
| Cell Movement | 1 | 2002 | 301 | 0.010 |
Why?
| Cell Line | 1 | 2004 | 1226 | 0.010 |
Why?
| Hippocampus | 1 | 2002 | 243 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2002 | 1571 | 0.010 |
Why?
| DNA Restriction Enzymes | 2 | 1986 | 16 | 0.010 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1986 | 105 | 0.010 |
Why?
| Cloning, Molecular | 2 | 1986 | 224 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1986 | 63 | 0.000 |
Why?
| Molecular Weight | 1 | 1985 | 106 | 0.000 |
Why?
| Transcription, Genetic | 1 | 1986 | 465 | 0.000 |
Why?
| Escherichia coli | 1 | 1985 | 247 | 0.000 |
Why?
|
|
Ware's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|